| Title | Claps | Level | Year | L/Y |
|---|---|---|---|---|
|
Rheumatic and Musculoskeletal Immune‐Related Adverse Events Due to Immune Checkpoint Inhibitors: A Systematic Review of the Literature
L. Cappelli, Anna Kristina Gutierrez, C. Bingham, Ami A. Shah
Immune checkpoint inhibitors (ICIs) are improving prognoses in advanced stage cancers, but they also lead to immune‐related adverse events (IRAEs). IRAEs targeting many organ systems have been reported, but musculoskeletal and rheumatic IRAEs have n…
Immune checkpoint inhibitors (ICIs) are improving prognoses in advanced stage cancers, but they also lead to immune‐related adverse events (IRAEs). IRAEs targeting many organ systems have been reported, but musculoskeletal and rheumatic IRAEs have not been well‐characterized. We systematically reviewed published literature on musculoskeletal and rheumatic IRAEs to better understand prevalence and clinical characteristics.
Published in
Arthritis care & research
|
62
|
8 | 2017 |
Social Media Posts